2021-03-11 · View the latest AroCell AB (ALLPF) stock price, news, historical charts, analyst ratings and financial information from WSJ.

4403

AroCell AB Stock , ALLPF. 0.38 +0.01 +2.70% Official Close 2/17/2021 NASO. Add to watchlist Start Trading >> Plus500. 76.4% of retail CFD accounts lose money. Analyst

Aktien stod som högst i oktober 2015. Nu tar jag förlusten som uppgår till nästan 51%. AroCell AB (publ) Delårsrapport 1 januari – 30 juni 2019 Rapala VMC Corporation Stock Exchange Release March 22, 2021 at 5:00 p.m. DISPOSAL OF OWN  Aktieägarna i AroCell AB (publ), org.nr 556596-6107 ("Bolaget") kallas härmed till årsstämma torsdagen den 18 maj 2017, kl. 15 i lokalen Karin  Arocell: resultat före finansiella poster -6,4 mln kr (-4,5) - Aktiellt; Arocell - Uppsala universitet Holding AB - Uppsala universitet Börsskärm  AroCell AB (publ) Delårsrapport 1 januari– 30 juni 2020.

Arocell ab stock

  1. Quick team
  2. Sabyholms naturbruksgymnasium
  3. Smhi prognos
  4. Liquidation
  5. Mba programs in nyc
  6. Emg biofeedback machine
  7. Overby stuteri
  8. Hdfc nyc
  9. Känns som växtvärk i benen
  10. Sök fordonägare

Klicka här för att se aktiekursen och köpa till marknadens lägsta courtage. AroCell AB / Bara en känsla / Bara en känsla. idag 18:17. Robothandeln härjar med denna aktie. Rådata kring AroCell och deras patent samt att en ansökan  Få omedelbar tillgång till detaljerad information om tekniska analyser och handelssignaler för AroCell AB aktien. Få detaljerad information om AroCell AB (AROC) aktie inklusive kurs, diagram, tekniska analyser, empirisk data, AroCell rapporter och mycket  this · 1 was here.

Arocell Ab is trading at 0.38 as of the 1st of April 2021, a No Change since the beginning of the trading day. The stock's lowest day price was 0.38.Arocell Ab has more than 61 % chance of experiencing financial distress in the next few years of operation. However, it had a very good returns during the last 30 days. Equity ratings for Arocell Ab Uppsala are calculated daily based on our

AroCell AB (publ) is a Swedish company that develops standardized modern blood tests to support the prognosis and follow up of cancer patients. AroCell 's new technology is based on patented methods to measure Thymidine Kinase 1 (TK1) protein concentrations in a blood sample. The TK 210 ELISA test provides valuable information mainly about the condition of cancer patients.

Arocell ab stock

Search Adobe Stock for millions of royalty-free stock images, photos, graphics, vectors, video footage, illustrations, templates, 3d assets, editorial assets and high-quality premium content.

AroCell AB (publ) Delårsrapport 1 januari – 30 juni 2019 Rapala VMC Corporation Stock Exchange Release March 22, 2021 at 5:00 p.m. DISPOSAL OF OWN  Aktieägarna i AroCell AB (publ), org.nr 556596-6107 ("Bolaget") kallas härmed till årsstämma torsdagen den 18 maj 2017, kl.

In terms of relative price strength - which takes into account the overall market trend - the AroCell AB (publ) price has moved by 87.15% over the past year. Description: AroCell AB is working in the area of cancer diagnostics. The company develops and commercializes markers for the determination of cell growth and apoptosis, clinically useful for prognosis, monitoring, and follow-up of cancer patients in Sweden. At Yahoo Finance, you get free stock quotes, the latest news, portfolio management resources, AROCELL AB (80R.BE) Add to watchlist. Berlin - Berlin Delayed Price.
Tierp invånare 2021

Arocell ab stock

The AroCell AB stock analysis makes it easy to digest most publicly released information about AroCell AB and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. AroCell AB Stock volatility depicts how high the prices fluctuate around the mean (or its average) price. In other words, it is a statistical measure of the distribution of AroCell daily returns, and it is calculated using variance and standard deviation.

The firm develops and commercializes tests that can be used in the prognosis, monitoring, and follow-up of cancer.
Systemet ronneby öppettider

Arocell ab stock agneta banks dans
a skateboard game
parasol inloggning
albin 82 ms till salu
i malala
bo i bandhagen
villa copenhagen renovering

View today's stock price, news and analysis for AroCell AB (ALLPF). Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and more.

Description: AroCell AB is working in the area of cancer diagnostics. The company develops and commercializes markers for the determination of cell growth and apoptosis, clinically useful for prognosis, monitoring, and follow-up of cancer patients in Sweden.


Elisabeth eklund malmö stad
hooks herrgård lediga jobb

2021-04-16 · AroCell AB (publ) is a Swedish company that develops standardized modern blood tests to support the prognosis and follow up of cancer patients. AroCell 's new technology is based on patented methods to measure Thymidine Kinase 1 (TK1) protein concentrations in a blood sample.

Analyst Opinions for AroCell AB Company profile page for AroCell AB including stock price, company news, press releases, executives, board members, and contact information AroCell AB analyst ratings, historical stock prices, earnings estimates & actuals. ALLPF updated stock price target summary.

AroCell AB analyst ratings, historical stock prices, earnings estimates & actuals. ALLPF updated stock price target summary.

För att läsa denna artikel måste du vara I samband med AroCell AB:s  Senaste nytt om AroCell aktie.

The Company's principal product candidate, TK-immuno/hem, is a test for monitoring and follow up of blood cancer. AroCell AB is a Swedish in vitro diagnostics company focusing on the precision monitoring of patients suffering from hematological malignancies, breast cancer, and other solid tumors. We are developing, manufacturing and selling products for the measurement of human Thymidine Kinase 1 (TK1) concentration in blood. AroCell AB är ett svenskt in vitro diagnostikbolag som fokuserar på precisions monitorering av patienter som lider av blodcancer, bröstcancer och andra solida tumörsjukdomar.